Pharmacology
- You have accessRestricted accessIs Plasma Renin Activity Genetically Determined and How Much Does It Matter for Treating Hypertension?Francois Alhenc-Gelas and Joel MenardCirc Genom Precis Med. 2018;11:e002139, originally published April 12, 2018https://doi.org/10.1161/CIRCGEN.118.002139
- You have accessRestricted accessGenetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses)Caitrin W. McDonough, Oyunbileg Magvanjav, Ana C.C. Sá, Nihal M. El Rouby, Chintan Dave, Amelia N. Deitchman, Marina Kawaguchi-Suzuki, Wenbin Mei, Yong Shen, Ravi Shankar Prasad Singh, Mohamed Solayman, Kent R. Bailey, Eric Boerwinkle, Arlene B. Chapman, John G. Gums, Amy Webb, Steven E. Scherer, Wolfgang Sadee, Stephen T. Turner, Rhonda M. Cooper-DeHoff, Yan Gong and Julie A. JohnsonCirc Genom Precis Med. 2018;11:e001854, originally published April 12, 2018https://doi.org/10.1161/CIRCGEN.117.001854
- You have accessRestricted accessClinical Outcomes and Sustainability of Using CYP2C19 Genotype–Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCraig R. Lee, Vindhya B. Sriramoju, Alexandra Cervantes, Lucius A. Howell, Nicholas Varunok, Shivanshu Madan, Kasey Hamrick, Melissa J. Polasek, John Andrew Lee, Megan Clarke, Jonathan D. Cicci, Karen E. Weck and George A. StoufferCirc Genom Precis Med. 2018;11:e002069, originally published April 3, 2018https://doi.org/10.1161/CIRCGEN.117.002069
- You have accessRestricted accessImplementation of Genotype-Guided Antiplatelet TherapyFeasible but Not Without ObstaclesJoshua P. LewisCirc Genom Precis Med. 2018;11:e002118, originally published April 3, 2018https://doi.org/10.1161/CIRCGEN.118.002118
- You have accessRestricted accessStatin Effects on Metabolic ProfilesCLINICAL PERSPECTIVEData From the PREVEND IT (Prevention of Renal and Vascular End-stage Disease Intervention Trial)Daniel Kofink, Ruben N. Eppinga, Wiek H. van Gilst, Stephan J.L. Bakker, Robin P.F. Dullaart, Pim van der Harst and Folkert W. AsselbergsCirculation: Genomic and Precision Medicine. 2017;10:e001759, originally published December 13, 2017https://doi.org/10.1161/CIRCGENETICS.117.001759
- Open AccessGenotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and InflammationCLINICAL PERSPECTIVEConcordance With Clinical OutcomesJean-Claude Tardif, David Rhainds, Mathieu Brodeur, Yassamin Feroz Zada, René Fouodjio, Sylvie Provost, Marie Boulé, Sonia Alem, Jean C. Grégoire, Philippe L. L’Allier, Reda Ibrahim, Marie-Claude Guertin, Ian Mongrain, Anders G. Olsson, Gregory G. Schwartz, Eric Rhéaume and Marie-Pierre DubéCirculation: Genomic and Precision Medicine. 2016;9:340-348, originally published July 14, 2016https://doi.org/10.1161/CIRCGENETICS.116.001405
- You have accessRestricted accessSo Far, PCSK9 Inhibitors Work for All Heterozygous FH PatientsMarkey C. McNutt and Zahid AhmadCirculation: Genomic and Precision Medicine. 2015;8:749-751, originally published December 15, 2015https://doi.org/10.1161/CIRCGENETICS.115.001256
- Open AccessCharacterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyCLINICAL PERSPECTIVEPaul N. Hopkins, Joep Defesche, Sigrid W. Fouchier, Eric Bruckert, Gérald Luc, Bertrand Cariou, Barbara Sjouke, Trond P. Leren, Mariko Harada-Shiba, Hiroshi Mabuchi, Jean-Pierre Rabès, Alain Carrié, Charles van Heyningen, Valérie Carreau, Michel Farnier, Yee P. Teoh, Mafalda Bourbon, Masa-aki Kawashiri, Atsushi Nohara, Handrean Soran, A. David Marais, Hayato Tada, Marianne Abifadel, Catherine Boileau, Bernard Chanu, Shoji Katsuda, Ichiro Kishimoto, Gilles Lambert, Hisashi Makino, Yoshihiro Miyamoto, Matthieu Pichelin, Kunimasa Yagi, Masakazu Yamagishi, Yassine Zair, Scott Mellis, George D. Yancopoulos, Neil Stahl, Johanna Mendoza, Yunling Du, Sara Hamon, Michel Krempf and Gary D. SwergoldCirculation: Genomic and Precision Medicine. 2015;8:823-831, originally published September 15, 2015https://doi.org/10.1161/CIRCGENETICS.115.001129
- You have accessRestricted accessFinding the Therapeutic Sweet SpotUsing Naturally Occurring Human Variants to Inform Drug DesignJohn R. Burnett and Robert A. HegeleCirculation: Genomic and Precision Medicine. 2015;8:637-639, originally published October 20, 2015https://doi.org/10.1161/CIRCGENETICS.115.001219
- You have accessRestricted accessEffect of Bile Acid Sequestrants on the Risk of Cardiovascular EventsCLINICAL PERSPECTIVEA Mendelian Randomization AnalysisStephanie Ross, Matthew D’Mello, Sonia S. Anand, John Eikelboom, CARDIoGRAMplusC4D Consortium*, Alexandre F.R. Stewart, Nilesh J. Samani, Robert Roberts and Guillaume ParéCirculation: Genomic and Precision Medicine. 2015;8:618-627, originally published June 4, 2015https://doi.org/10.1161/CIRCGENETICS.114.000952
Pages
Current Issue
Circ Genom Precis Med
April 2018, Volume 11, Issue 4
Search This Journal
Related Collections
- Anticoagulants (3)
- Pacemaker (3)
- Pharmacology (45)
- Treatment (19)